These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3260414)

  • 1. The interaction of von Willebrand factor (vWf) with collagen: investigation of vWf-binding sites in the collagen molecule.
    Fitzsimmons CM; Cockburn CG; Hornsey V; Prowse CV; Barnes MJ
    Thromb Haemost; 1988 Apr; 59(2):186-92. PubMed ID: 3260414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction of fibronectin (fn) with native, polymeric collagen (collagen fibres): comparison with von Willebrand factor (vWf)-binding by collagen.
    Cockburn CG; Fitzsimmons CM; Barnes MJ
    Thromb Haemost; 1989 Jun; 61(3):378-85. PubMed ID: 2799752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The platelet reactivity of collagen type I: evidence for multiple platelet-reactive sites in the type I collagen molecule.
    Fitzsimmons CM; Cawston TE; Barnes MJ
    Thromb Haemost; 1986 Aug; 56(1):95-9. PubMed ID: 3022415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adhesive domains in the collagen III fragment alpha1(III)CB4 that support alpha2beta1- and von Willebrand factor-mediated platelet adhesion under flow conditions.
    Verkleij MW; IJsseldijk MJ; Heijnen-Snyder GJ; Huizinga EG; Morton LF; Knight CG; Sixma JJ; de Groot PG; Barnes MJ
    Thromb Haemost; 1999 Sep; 82(3):1137-44. PubMed ID: 10494778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of von Willebrand factor to collagen type III: role of specific amino acids in the collagen binding domain of vWF and effects of neighboring domains.
    van der Plas RM; Gomes L; Marquart JA; Vink T; Meijers JC; de Groot PG; Sixma JJ; Huizinga EG
    Thromb Haemost; 2000 Dec; 84(6):1005-11. PubMed ID: 11154106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.
    Houdijk WP; Sakariassen KS; Nievelstein PF; Sixma JJ
    J Clin Invest; 1985 Feb; 75(2):531-40. PubMed ID: 3919060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A3 domain is essential for interaction of von Willebrand factor with collagen type III.
    Lankhof H; van Hoeij M; Schiphorst ME; Bracke M; Wu YP; Ijsseldijk MJ; Vink T; de Groot PG; Sixma JJ
    Thromb Haemost; 1996 Jun; 75(6):950-8. PubMed ID: 8822592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of two von Willebrand factor collagen-binding assays with different binding affinities for low, medium, and high multimers of von Willebrand factor.
    Neugebauer BM; Goy C; Budek I; Seitz R
    Semin Thromb Hemost; 2002 Apr; 28(2):139-48. PubMed ID: 11992237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of the platelet-binding domain of von Willebrand factor.
    Silverman C; Mascelli MA; Karl DW; Kirby EP
    J Lab Clin Med; 1987 Jul; 110(1):113-8. PubMed ID: 3496407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A monoclonal antibody recognizes a von Willebrand factor domain within the amino-terminal portion of the subunit that modulates the function of the glycoprotein IB- and IIB/IIIA-binding domains.
    Tornai I; Arnout J; Deckmyn H; Peerlinck K; Vermylen J
    J Clin Invest; 1993 Jan; 91(1):273-82. PubMed ID: 8423224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping and functional studies of two alloantibodies developed in patients with type 3 von Willebrand disease.
    Tout H; Obert B; Houllier A; Fressinaud E; Rothschild C; Meyer D; Girma JP
    Thromb Haemost; 2000 Feb; 83(2):274-81. PubMed ID: 10739386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence alignment between vWF and peptides inhibiting the vWF-collagen interaction does not result in the identification of a collagen-binding site in vWF.
    Vanhoorelbeke K; van der Plas RM; Vandecasteele G; Vauterin S; Huizinga EG; Sixma JJ; Deckmyn H
    Thromb Haemost; 2000 Oct; 84(4):621-5. PubMed ID: 11057860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ser968Thr mutation within the A3 domain of von Willebrand factor (VWF) in two related patients leads to a defective binding of VWF to collagen.
    Ribba AS; Loisel I; Lavergne JM; Juhan-Vague I; Obert B; Cherel G; Meyer D; Girma JP
    Thromb Haemost; 2001 Sep; 86(3):848-54. PubMed ID: 11583318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
    Dean JA; Blanchette VS; Carcao MD; Stain AM; Sparling CR; Siekmann J; Turecek PL; Lillicrap D; Rand ML
    Thromb Haemost; 2000 Sep; 84(3):401-9. PubMed ID: 11019962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The secondary structure of the von Willebrand factor type A domain in factor B of human complement by Fourier transform infrared spectroscopy. Its occurrence in collagen types VI, VII, XII and XIV, the integrins and other proteins by averaged structure predictions.
    Perkins SJ; Smith KF; Williams SC; Haris PI; Chapman D; Sim RB
    J Mol Biol; 1994 Apr; 238(1):104-19. PubMed ID: 8145250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of human von Willebrand factor to collagen and to collagen-stimulated platelets.
    Pietu G; Fressinaud E; Girma JP; Nieuwenhuis HK; Rothschild C; Meyer D
    J Lab Clin Med; 1987 Jun; 109(6):637-46. PubMed ID: 3495619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collagen binding assay for von Willebrand factor (VWF:CBA): detection of von Willebrands Disease (VWD), and discrimination of VWD subtypes, depends on collagen source.
    Favaloro EJ
    Thromb Haemost; 2000 Jan; 83(1):127-35. PubMed ID: 10669166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-vessel wall interactions in thrombosis and restenosis role of von Willebrand factor.
    Hoylaerts MF
    Verh K Acad Geneeskd Belg; 1997; 59(3):161-83. PubMed ID: 9490916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study on collagen-binding enzyme-linked immunosorbent assay and ristocetin cofactor activity assays for detection of functional activity of von Willebrand factor.
    Turecek PL; Siekmann J; Schwarz HP
    Semin Thromb Hemost; 2002 Apr; 28(2):149-60. PubMed ID: 11992238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological activity of von Willebrand factor during the manufacture of therapeutic factor VIII concentrates as determined by the collagen-binding assay.
    Ramasamy I; Farrugia A; Tran E; Anastasius V; Charnock A
    Biologicals; 1998 Jun; 26(2):155-66. PubMed ID: 9811523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.